Expired Tender USA ICB TOT Ref. 116731910

A Human Multi-Organ Tissue Equivalent Platform Tender - 116731910

Tender notice from USA, published on 25 Mar 2025.

Executive Summary

The DEPT OF DEFENSE | DEFENSE HEALTH AGENCY (DHA) has issued a Tender notice for the procurement of a A Human Multi-Organ Tissue Equivalent Platform to Model High Consequence Threat Agents in the USA. This Tender notice was published on 25 Mar 2025 and is scheduled to close on 14 Apr 2025, with an estimated Tender value of Refer Document. Interested bidders can access detailed Tender information, eligibility criteria, and complete bidding documents by referencing TOT Ref No. 116731910, while the tender notice number is HT942525R0053 and Register on the platform.

Key facts

Summary
A Human Multi-Organ Tissue Equivalent Platform to Model High Consequence Threat Agents
TOT Ref. No.
116731910
Document Ref. No.
HT942525R0053
Country
USA
Notice type
Tender
Competition
ICB
Publication date
25 Mar 2025
Bid deadline
14 Apr 2025
EMD
Refer Document
Tender value
Refer Document
Purchaser ownership
Public
Financier
Self Financed

Purchaser details

Purchaser contact is for registered users

Login to see details

Tender details

Description
The United States Army Medical Research Acquisition Activity (USAMRAA) intends to issue a Firm Fixed Price sole source contract under the authority of FAR 6.302-1 (a) (2) - Only One Responsible Source and No Other Services will Satisfy Agency Requirements to Wake Forest Institute for Regenerative Medicine (WFIRM), Winston-Salem, NC, on behalf of the United States Army Medical Research of Infectious Diseases (USAMRIID).
The Government has a requirement for the development of a micro engineered human organ/tissue equivalent platform for modeling the pathogenic outcomes of emerging infectious diseases and test the efficacy of medical countermeasures (MCMs). The scope of effort will encompass the task of protecting the warfighter from a natural or manmade attack and have the ability to rapidly identify the best methods available to maintain mission critical status. The Contractor will conduct all activities in compliance with FDA CVM regulations, current Good Manufacturing Processes (cGMP), and other applicable regulations as necessary. The Government seeks an Organ Tissue Equivalent (OTE) platform, which utilizes cutting edge 3D organ-on-a-chip technologies and offers one such solution for the military by providing a tool for rapidly identifying medical countermeasures for the prevention and treatment of emerging viral diseases. The lung OTE shall be comprised entirely of human cells including the epithelial, endothelial, stromal, and inflammatory components of native lung tissue. Unlike typical 2D systems, these constructs shall be arranged in a pseudostratified architecture and produce mucus and surfactant providing a physiologically relevant model system. The overarching goal of the proposed studies is to validate the human lung construct as a flexible model for viral pulmonary infections and the resultant inflammatory response. The system will also be used to test the efficacy of potential medical countermeasures, and for identifying potential d...
Active Contract Opportunity

Notice ID : HT942525R0053

Related Notice

Department/Ind. Agency : DEPT OF DEFENSE

Sub-tier : DEFENSE HEALTH AGENCY (DHA)

Office: ARMY MED RES ACQ ACTIVITY

General Information

Contract Opportunity Type: Special Notice (Original)

Original Published Date: Mar 24, 2025 04:12 pm EDT

Original Response Date: Apr 14, 2025 10:00 am EDT

Inactive Policy: 15 days after response date

Original Inactive Date: Apr 29, 2025

Initiative: None
Classification

Original Set Aside:

Product Service Code: AJ13 - GENERAL SCIENCE & TECHNOLOGY R&D SVCS; GENERAL SCIENCE & TECHNOLOGY; EXPERIMENTAL DEVELOPMENT

NAICS Code: 621511 - Medical Laboratories
Place of Performance: MD USA

Documents

Tender Notice
Login to view

USA Public Procurement Intelligence

Frequently asked questions

The bid deadline for A Human Multi-Organ Tissue Equivalent Platform to Model High Consequence Threat Agents was 14 Apr 2025. Bidding is closed.

This tender has been issued by DEPT OF DEFENSE | DEFENSE HEALTH AGENCY (DHA) in USA.

The tender value is not disclosed; please refer to the tender document. EMD / bid security details are provided in the tender document.

This tender is Self Financed

The tender notice and related documents are listed in the Documents section above. Select a document to view or download it. Please log in or register to access the documents. If you cannot find additional documents in the Documents section, please log in to your account and Send Document Request from your account section.

The TendersOnTime reference is 116731910. The purchaser document reference is HT942525R0053.

Browse other tenders from USA or search by relevant keywords and CPV classification.